{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,23]],"date-time":"2023-09-23T17:29:59Z","timestamp":1695490199088},"reference-count":46,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2007,3,1]],"date-time":"2007-03-01T00:00:00Z","timestamp":1172707200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2007,3]]},"DOI":"10.1016\/j.vaccine.2006.11.063","type":"journal-article","created":{"date-parts":[[2006,12,13]],"date-time":"2006-12-13T17:11:16Z","timestamp":1166029876000},"page":"2296-2305","source":"Crossref","is-referenced-by-count":8,"title":["Evaluation of neurovirulence and biodistribution of Venezuelan equine encephalitis replicon particles expressing herpes simplex virus type 2 glycoprotein D"],"prefix":"10.1016","volume":"25","author":[{"given":"Jacek","family":"Kowalski","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karissa","family":"Adkins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seema","family":"Gangolli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian","family":"Ren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heather","family":"Arendt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joanne","family":"DeStefano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Obregon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donna","family":"Tummolo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert J.","family":"Natuk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tom P.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher L.","family":"Parks","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen A.","family":"Udem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deborah","family":"Long","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.vaccine.2006.11.063_bib1","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1006\/viro.1997.8878","article-title":"Replicon-helper systems from attenuated Venezuelan equine encephalitis virus: expression of heterologous genes in vitro and immunization against heterologous pathogens in vivo","volume":"239","author":"Pushko","year":"1997","journal-title":"Virology"},{"issue":"4","key":"10.1016\/j.vaccine.2006.11.063_bib2","doi-asserted-by":"crossref","first-page":"2819","DOI":"10.1128\/JVI.71.4.2819-2829.1997","article-title":"Sindbis virus replicons and Sindbis virus: assembly of chimeras and of particles deficient in virus RNA","volume":"71","author":"Frolov","year":"1997","journal-title":"J Virol"},{"issue":"2","key":"10.1016\/j.vaccine.2006.11.063_bib3","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1128\/JVI.73.2.1092-1098.1999","article-title":"Two-helper RNA system for production of recombinant Semliki forest virus particles","volume":"73","author":"Smerdou","year":"1999","journal-title":"J Virol"},{"issue":"9\u201310","key":"10.1016\/j.vaccine.2006.11.063_bib4","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/j.vaccine.2003.10.003","article-title":"Induction of cytotoxic T lymphocyte activity by immunization with recombinant Semliki Forest virus: indications for cross-priming","volume":"22","author":"Huckriede","year":"2004","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2006.11.063_bib5","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1128\/JVI.74.2.914-922.2000","article-title":"Role of dendritic cell targeting in Venezuelan equine encephalitis virus pathogenesis","volume":"74","author":"MacDonald","year":"2000","journal-title":"J Virol"},{"issue":"6857","key":"10.1016\/j.vaccine.2006.11.063_bib6","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1038\/35099560","article-title":"Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3","volume":"413","author":"Alexopoulou","year":"2001","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.vaccine.2006.11.063_bib7","first-page":"673","article-title":"Two ways to induce innate immune responses in human PBMCs: paracrine stimulation of IFN-alpha responses by viral protein or dsRNA","volume":"23","author":"Fournier","year":"2003","journal-title":"Int J Oncol"},{"issue":"1","key":"10.1016\/j.vaccine.2006.11.063_bib8","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1128\/JVI.74.1.371-378.2000","article-title":"Vaccination of macaques against pathogenic simian immunodeficiency virus with Venezuelan equine encephalitis virus replicon particles","volume":"74","author":"Davis","year":"2000","journal-title":"J Virol"},{"issue":"22","key":"10.1016\/j.vaccine.2006.11.063_bib9","doi-asserted-by":"crossref","first-page":"10623","DOI":"10.1128\/JVI.74.22.10623-10630.2000","article-title":"Expression of the two major envelope proteins of equine arteritis virus as a heterodimer is necessary for induction of neutralizing antibodies in mice immunized with recombinant Venezuelan equine encephalitis virus replicon particles","volume":"74","author":"Balasuriya","year":"2000","journal-title":"J Virol"},{"issue":"1","key":"10.1016\/j.vaccine.2006.11.063_bib10","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1006\/viro.2000.0635","article-title":"Influenza virus (A\/HK\/156\/97) hemagglutinin expressed by an alphavirus replicon system protects chickens against lethal infection with Hong Kong-origin H5N1 viruses","volume":"278","author":"Schultz-Cherry","year":"2000","journal-title":"Virology"},{"issue":"9","key":"10.1016\/j.vaccine.2006.11.063_bib11","doi-asserted-by":"crossref","first-page":"5709","DOI":"10.1128\/IAI.69.9.5709-5715.2001","article-title":"Candidate vaccine against botulinum neurotoxin serotype A derived from a Venezuelan equine encephalitis virus vector system","volume":"69","author":"Lee","year":"2001","journal-title":"Infect Immun"},{"issue":"3\u20134","key":"10.1016\/j.vaccine.2006.11.063_bib12","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/S0264-410X(02)00455-3","article-title":"Evaluation of FIV protein-expressing VEE-replicon vaccine vectors in cats","volume":"21","author":"Burkhard","year":"2002","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/j.vaccine.2006.11.063_bib13","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1086\/339677","article-title":"Immune protection against staphylococcal enterotoxin-induced toxic shock by vaccination with a Venezuelan equine encephalitis virus replicon","volume":"185","author":"Lee","year":"2002","journal-title":"J Infect Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2006.11.063_bib14","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1128\/JVI.76.2.730-742.2002","article-title":"Systemic, mucosal, and heterotypic immune induction in mice inoculated with Venezuelan equine encephalitis replicons expressing Norwalk virus-like particles","volume":"76","author":"Harrington","year":"2002","journal-title":"J Virol"},{"issue":"25\u201326","key":"10.1016\/j.vaccine.2006.11.063_bib15","doi-asserted-by":"crossref","first-page":"3875","DOI":"10.1016\/S0264-410X(03)00307-4","article-title":"Evaluation of Venezuelan Equine Encephalitis (VEE) replicon-based Outer surface protein A (OspA) vaccines in a tick challenge mouse model of Lyme disease","volume":"21","author":"Gipson","year":"2003","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2006.11.063_bib16","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1128\/IAI.71.3.1491-1496.2003","article-title":"Venezuelan equine encephalitis virus-vectored vaccines protect mice against anthrax spore challenge","volume":"71","author":"Lee","year":"2003","journal-title":"Infect Immun"},{"issue":"3","key":"10.1016\/j.vaccine.2006.11.063_bib17","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1023\/B:BREA.0000004373.09678.bb","article-title":"Venezuelan equine encephalitis replicon immunization overcomes intrinsic tolerance and elicits effective anti-tumor immunity to the \u2018self\u2019 tumor-associated antigen, neu in a rat mammary tumor model","volume":"82","author":"Nelson","year":"2003","journal-title":"Breast Cancer Res Treat"},{"issue":"3\u20134","key":"10.1016\/j.vaccine.2006.11.063_bib18","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.vaccine.2003.07.003","article-title":"Antitumor efficacy of Venezuelan equine encephalitis virus replicon particles encoding mutated HPV16 E6 and E7 genes","volume":"22","author":"Cassetti","year":"2004","journal-title":"Vaccine"},{"issue":"22","key":"10.1016\/j.vaccine.2006.11.063_bib19","doi-asserted-by":"crossref","first-page":"8114","DOI":"10.1158\/1078-0432.CCR-05-1410","article-title":"Comparison of two cancer vaccines targeting tyrosinase: plasmid DNA and recombinant alphavirus replicon particles","volume":"11","author":"Goldberg","year":"2005","journal-title":"Clin Cancer Res"},{"issue":"3","key":"10.1016\/j.vaccine.2006.11.063_bib20","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.jcv.2005.12.001","article-title":"Recombinant alphaviruses as vectors for anti-tumour and anti-microbial immunotherapy","volume":"35","author":"Riezebos-Brilman","year":"2006","journal-title":"J Clin Virol"},{"issue":"3","key":"10.1016\/j.vaccine.2006.11.063_bib21","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1128\/JVI.68.3.1721-1727.1994","article-title":"Comparison of the effects of Sindbis virus and Sindbis virus replicons on host cell protein synthesis and cytopathogenicity in BHK cells","volume":"68","author":"Frolov","year":"1994","journal-title":"J Virol"},{"issue":"5","key":"10.1016\/j.vaccine.2006.11.063_bib22","doi-asserted-by":"crossref","first-page":"3935","DOI":"10.1128\/JVI.72.5.3935-3943.1998","article-title":"The transmembrane domains of Sindbis virus envelope glycoproteins induce cell death","volume":"72","author":"Joe","year":"1998","journal-title":"J Virol"},{"issue":"2","key":"10.1016\/j.vaccine.2006.11.063_bib23","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1006\/viro.1995.1022","article-title":"Specific restrictions in the progression of Venezuelan equine encephalitis virus-induced disease resulting from single amino acid changes in the glycoproteins","volume":"206","author":"Grieder","year":"1995","journal-title":"Virology"},{"issue":"2","key":"10.1016\/j.vaccine.2006.11.063_bib24","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1006\/viro.1996.8381","article-title":"Mucosal immunity induced by parenteral immunization with a live attenuated Venezuelan equine encephalitis virus vaccine candidate","volume":"228","author":"Charles","year":"1997","journal-title":"Virology"},{"issue":"2","key":"10.1016\/j.vaccine.2006.11.063_bib25","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1006\/viro.1995.1197","article-title":"Mechanism of neuroinvasion of Venezuelan equine encephalitis virus in the mouse","volume":"208","author":"Charles","year":"1995","journal-title":"Virology"},{"issue":"2","key":"10.1016\/j.vaccine.2006.11.063_bib26","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1006\/viro.2001.0878","article-title":"Immunopathogenesis and immune modulation of Venezuelan equine encephalitis virus-induced disease in the mouse","volume":"284","author":"Charles","year":"2001","journal-title":"Virology"},{"issue":"5","key":"10.1016\/j.vaccine.2006.11.063_bib27","doi-asserted-by":"crossref","first-page":"3854","DOI":"10.1128\/JVI.73.5.3854-3865.1999","article-title":"Selection of RNA replicons capable of persistent noncytopathic replication in mammalian cells","volume":"73","author":"Frolov","year":"1999","journal-title":"J Virol"},{"issue":"12","key":"10.1016\/j.vaccine.2006.11.063_bib28","doi-asserted-by":"crossref","first-page":"5686","DOI":"10.1128\/JVI.02739-05","article-title":"Sindbis virus nonstructural protein nsP2 is cytotoxic and inhibits cellular transcription","volume":"80","author":"Garmashova","year":"2006","journal-title":"J Virol"},{"issue":"10","key":"10.1016\/j.vaccine.2006.11.063_bib29","doi-asserted-by":"crossref","first-page":"4579","DOI":"10.1128\/JVI.74.10.4579-4589.2000","article-title":"Replicase complex genes of Semliki Forest virus confer lethal neurovirulence","volume":"74","author":"Tuittila","year":"2000","journal-title":"J Virol"},{"issue":"Part 4","key":"10.1016\/j.vaccine.2006.11.063_bib30","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1099\/vir.0.81406-0","article-title":"Deletions in the hypervariable domain of the nsP3 gene attenuate Semliki Forest virus virulence","volume":"87","author":"Galbraith","year":"2006","journal-title":"J Gen Virol"},{"issue":"2","key":"10.1016\/j.vaccine.2006.11.063_bib31","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0166-0934(03)00063-6","article-title":"A method of alphavirus replicon particle titration based on expression of functional replicase\/transcriptase","volume":"109","author":"Gangolli","year":"2003","journal-title":"J Virol Meth"},{"issue":"1","key":"10.1016\/j.vaccine.2006.11.063_bib32","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/0042-6822(91)90114-Q","article-title":"Attenuating mutations in the E2 glycoprotein gene of Venezuelan equine encephalitis virus: construction of single and multiple mutants in a full-length cDNA clone","volume":"183","author":"Davis","year":"1991","journal-title":"Virology"},{"issue":"1","key":"10.1016\/j.vaccine.2006.11.063_bib33","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1006\/viro.2000.0546","article-title":"Mutations in the E2 glycoprotein of Venezuelan equine encephalitis virus confer heparan sulfate interaction, low morbidity, and rapid clearance from blood of mice","volume":"276","author":"Bernard","year":"2000","journal-title":"Virology"},{"issue":"3","key":"10.1016\/j.vaccine.2006.11.063_bib34","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1128\/JVI.67.3.1269-1277.1993","article-title":"Attenuation of Venezuelan equine encephalitis virus strain TC-83 is encoded by the 5\u2032-noncoding region and the E2 envelope glycoprotein","volume":"67","author":"Kinney","year":"1993","journal-title":"J Virol"},{"issue":"(1\u20132)","key":"10.1016\/j.vaccine.2006.11.063_bib35","doi-asserted-by":"crossref","first-page":"49","DOI":"10.4269\/ajtmh.2001.64.49","article-title":"Comparative neurovirulence of attenuated and non-attenuated strains of Venezuelan equine encephalitis virus in mice","volume":"64","author":"Ludwig","year":"2001","journal-title":"Am J Trop Med Hyg"},{"issue":"3","key":"10.1016\/j.vaccine.2006.11.063_bib36","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1128\/MMBR.58.3.491-562.1994","article-title":"The alphaviruses: gene expression, replication, and evolution","volume":"58","author":"Strauss","year":"1994","journal-title":"Microbiol Rev"},{"issue":"2","key":"10.1016\/j.vaccine.2006.11.063_bib37","first-page":"161","article-title":"Equine amplification and virulence of subtype IE Venezuelan equine encephalitis viruses isolated during the 1993 and 1996 Mexican epizootics","volume":"9","author":"Gonzalez-Salazar","year":"2003","journal-title":"Emerg Infect Dis"},{"issue":"5\u20136","key":"10.1016\/j.vaccine.2006.11.063_bib38","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1177\/0300985875012005-00605","article-title":"Mouse encephalitis induced by avirulent Semliki forest virus","volume":"12","author":"Chew-Lim","year":"1975","journal-title":"Vet Pathol"},{"issue":"21","key":"10.1016\/j.vaccine.2006.11.063_bib39","doi-asserted-by":"crossref","first-page":"10431","DOI":"10.1128\/JVI.75.21.10431-10445.2001","article-title":"Identification of genes involved in the host response to neurovirulent alphavirus infection","volume":"75","author":"Johnston","year":"2001","journal-title":"J Virol"},{"issue":"3","key":"10.1016\/j.vaccine.2006.11.063_bib40","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/j.bbrc.2005.08.209","article-title":"Viruses selectively upregulate Toll-like receptors in the central nervous system","volume":"336","author":"McKimmie","year":"2005","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.vaccine.2006.11.063_bib41","first-page":"1537","article-title":"Apoptosis is essential for the increased efficacy of alphaviral replicase-based DNA vaccines","author":"Leitner","year":"2004","journal-title":"Nat Med"},{"issue":"4","key":"10.1016\/j.vaccine.2006.11.063_bib42","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/0264-410X(95)00168-Z","article-title":"Long-term duration of detectable neutralizing antibodies after administration of live-attenuated VEE vaccine and following booster vaccination with inactivated VEE vaccine","volume":"14","author":"Pittman","year":"1996","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/j.vaccine.2006.11.063_bib43","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1038\/sj.gt.3300458","article-title":"Expression of beta-galactosidase in mouse brain: utilization of a novel nonreplicative Sindbis virus vector as a neuronal gene delivery system","volume":"4","author":"Altman-Hamamdzic","year":"1997","journal-title":"Gene Ther"},{"key":"10.1016\/j.vaccine.2006.11.063_bib44","first-page":"15","article-title":"Efficient in vivo expression of a reporter gene in rat brain after injection of recombinant replication-deficient Semliki Forest virus","volume":"3","author":"Lundstrom","year":"1999","journal-title":"Gene Ther Mol Biol"},{"issue":"15\u201316","key":"10.1016\/j.vaccine.2006.11.063_bib45","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1016\/S0264-410X(00)00428-X","article-title":"Semliki Forest virus-based vaccines: persistence, distribution and pathological analysis in two animal systems","volume":"19","author":"Morris-Downes","year":"2001","journal-title":"Vaccine"},{"issue":"17","key":"10.1016\/j.vaccine.2006.11.063_bib46","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1038\/sj.gt.3301501","article-title":"Recombinant Semliki Forest virus vaccine vectors: the route of injection determines the localization of vector RNA and subsequent T cell response","volume":"8","author":"Colmenero","year":"2001","journal-title":"Gene Ther"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X06013016?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X06013016?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,19]],"date-time":"2020-04-19T08:02:09Z","timestamp":1587283329000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X06013016"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,3]]},"references-count":46,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2007,3]]}},"alternative-id":["S0264410X06013016"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2006.11.063","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2007,3]]}}}